• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于规则的推理框架,探索和解释潜在药物-药物相互作用的生物学相关机制。

A Rule-Based Inference Framework to Explore and Explain the Biological Related Mechanisms of Potential Drug-Drug Interactions.

机构信息

Department of Information Technology, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah 80221, Saudi Arabia.

Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.

出版信息

Comput Math Methods Med. 2022 Aug 17;2022:9093262. doi: 10.1155/2022/9093262. eCollection 2022.

DOI:10.1155/2022/9093262
PMID:36035294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9402322/
Abstract

As more drugs are developed and the incidence of polypharmacy increases, it is becoming critically important to anticipate potential DDIs before they occur in the clinic, along with those for which effects might go unobserved. However, traditional methods for DDI identification are unable to coalesce interaction mechanisms out of vast lists of potential or known DDIs, much less study them accurately. Computational methods have great promise but have realized only limited clinical utility. This work develops a rule-based inference framework to predict DDI mechanisms and support determination of their clinical relevance. Given a drug pair, our framework interrogates and describes DDI mechanisms based on a knowledge graph that integrates extensive available biomedical resources through semantic web technologies and backward chaining inference, effectively identifying facts within the graph that prove and explain the mechanisms of the drugs' interaction. The framework was evaluated through a case study combining a chemotherapy agent, irinotecan, and a widely used antibiotic, levofloxacin. The mutual interactions identified indicate that our framework can effectively explore and explain the mechanisms of potential DDIs. This approach has the potential to improve drug discovery and design and to support rapid and cost-effective identification of DDIs along with their putative mechanisms, a key step in determining clinical relevance and supporting clinical decision-making.

摘要

随着越来越多的药物被开发出来,同时伴随药物的联合使用(polypharmacy)的发生率增加,在药物在临床上出现潜在的药物相互作用(DDI)之前,预测这些相互作用变得至关重要,包括那些可能未被观察到的相互作用。然而,传统的 DDI 识别方法无法从大量潜在或已知的 DDI 列表中整合相互作用机制,更不用说准确地研究它们了。计算方法具有很大的潜力,但仅实现了有限的临床实用性。这项工作开发了一个基于规则的推理框架,以预测 DDI 机制,并支持确定其临床相关性。给定一对药物,我们的框架通过一个知识图来询问和描述 DDI 机制,该知识图通过语义 Web 技术和反向推理整合了广泛的可用生物医学资源,有效地在图中识别出证明和解释药物相互作用机制的事实。该框架通过一个案例研究进行了评估,该研究结合了一种化疗药物伊立替康和一种广泛使用的抗生素左氧氟沙星。确定的相互作用表明,我们的框架可以有效地探索和解释潜在 DDI 的机制。这种方法有可能改进药物发现和设计,并支持快速和具有成本效益的识别 DDI 及其潜在机制,这是确定临床相关性和支持临床决策的关键步骤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f4/9402322/fc857d0eb056/CMMM2022-9093262.alg.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f4/9402322/3dc150607a0c/CMMM2022-9093262.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f4/9402322/abfb29f5cabd/CMMM2022-9093262.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f4/9402322/13a5d9c3c619/CMMM2022-9093262.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f4/9402322/fc857d0eb056/CMMM2022-9093262.alg.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f4/9402322/3dc150607a0c/CMMM2022-9093262.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f4/9402322/abfb29f5cabd/CMMM2022-9093262.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f4/9402322/13a5d9c3c619/CMMM2022-9093262.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f4/9402322/fc857d0eb056/CMMM2022-9093262.alg.001.jpg

相似文献

1
A Rule-Based Inference Framework to Explore and Explain the Biological Related Mechanisms of Potential Drug-Drug Interactions.基于规则的推理框架,探索和解释潜在药物-药物相互作用的生物学相关机制。
Comput Math Methods Med. 2022 Aug 17;2022:9093262. doi: 10.1155/2022/9093262. eCollection 2022.
2
Drug-drug interaction discovery and demystification using Semantic Web technologies.利用语义网技术进行药物相互作用的发现与揭秘。
J Am Med Inform Assoc. 2017 May 1;24(3):556-564. doi: 10.1093/jamia/ocw128.
3
Prediction of Drug-Drug Interaction Using an Attention-Based Graph Neural Network on Drug Molecular Graphs.基于药物分子图的注意力图神经网络预测药物-药物相互作用。
Molecules. 2022 May 7;27(9):3004. doi: 10.3390/molecules27093004.
4
DINTO: Using OWL Ontologies and SWRL Rules to Infer Drug-Drug Interactions and Their Mechanisms.DINTO:使用OWL本体和SWRL规则推断药物相互作用及其机制。
J Chem Inf Model. 2015 Aug 24;55(8):1698-707. doi: 10.1021/acs.jcim.5b00119. Epub 2015 Aug 5.
5
A computational approach to predict multi-pathway drug-drug interactions: A case study of irinotecan, a colon cancer medication.一种预测多途径药物相互作用的计算方法:以结肠癌药物伊立替康为例。
Saudi Pharm J. 2020 Dec;28(12):1507-1513. doi: 10.1016/j.jsps.2020.09.017. Epub 2020 Sep 29.
6
Drug-Drug Interaction Predictions via Knowledge Graph and Text Embedding: Instrument Validation Study.通过知识图谱和文本嵌入进行药物-药物相互作用预测:工具验证研究
JMIR Med Inform. 2021 Jun 24;9(6):e28277. doi: 10.2196/28277.
7
SSI-DDI: substructure-substructure interactions for drug-drug interaction prediction.SSI-DDI:用于药物相互作用预测的结构-结构相互作用。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab133.
8
A Data-Driven Medical Decision Framework for Associating Adverse Drug Events with Drug-Drug Interaction Mechanisms.基于数据的药物不良事件与药物相互作用机制关联的医学决策框架。
J Healthc Eng. 2022 Mar 3;2022:9132477. doi: 10.1155/2022/9132477. eCollection 2022.
9
Anti-DDI Resource: A Dataset for Potential Negative Reported Interaction Combinations to Improve Medical Research and Decision-Making.抗药物-药物相互作用资源:一个用于潜在负面报告的相互作用组合的数据集,以改善医学研究和决策。
J Healthc Eng. 2022 Apr 9;2022:8904342. doi: 10.1155/2022/8904342. eCollection 2022.
10
Leveraging syntactic and semantic graph kernels to extract pharmacokinetic drug drug interactions from biomedical literature.利用句法和语义图核从生物医学文献中提取药代动力学药物相互作用。
BMC Syst Biol. 2016 Aug 26;10 Suppl 3(Suppl 3):67. doi: 10.1186/s12918-016-0311-2.

本文引用的文献

1
Anti-DDI Resource: A Dataset for Potential Negative Reported Interaction Combinations to Improve Medical Research and Decision-Making.抗药物-药物相互作用资源:一个用于潜在负面报告的相互作用组合的数据集,以改善医学研究和决策。
J Healthc Eng. 2022 Apr 9;2022:8904342. doi: 10.1155/2022/8904342. eCollection 2022.
2
A Data-Driven Medical Decision Framework for Associating Adverse Drug Events with Drug-Drug Interaction Mechanisms.基于数据的药物不良事件与药物相互作用机制关联的医学决策框架。
J Healthc Eng. 2022 Mar 3;2022:9132477. doi: 10.1155/2022/9132477. eCollection 2022.
3
Comparison of potential psychiatric drug interactions in six drug interaction database programs: A replication study after 2 years of updates.
六种药物相互作用数据库程序中潜在精神药物相互作用的比较:更新 2 年后的复制研究。
Hum Psychopharmacol. 2021 Nov;36(6):e2802. doi: 10.1002/hup.2802. Epub 2021 Jul 6.
4
A Minimal Information Model for Potential Drug-Drug Interactions.潜在药物相互作用的最小信息模型。
Front Pharmacol. 2021 Mar 8;11:608068. doi: 10.3389/fphar.2020.608068. eCollection 2020.
5
Evaluation of Pharmacokinetic Drug-Drug Interactions: A Review of the Mechanisms, In Vitro and In Silico Approaches.药代动力学药物-药物相互作用的评估:作用机制、体外和计算机模拟方法综述
Metabolites. 2021 Jan 27;11(2):75. doi: 10.3390/metabo11020075.
6
A New Era in Pharmacovigilance: Toward Real-World Data and Digital Monitoring.药物警戒新纪元:迈向真实世界数据和数字化监测。
Clin Pharmacol Ther. 2021 May;109(5):1197-1202. doi: 10.1002/cpt.2172. Epub 2021 Feb 28.
7
A computational approach to predict multi-pathway drug-drug interactions: A case study of irinotecan, a colon cancer medication.一种预测多途径药物相互作用的计算方法:以结肠癌药物伊立替康为例。
Saudi Pharm J. 2020 Dec;28(12):1507-1513. doi: 10.1016/j.jsps.2020.09.017. Epub 2020 Sep 29.
8
Applying knowledge-driven mechanistic inference to toxicogenomics.将知识驱动的机制推理应用于毒代动力学基因组学。
Toxicol In Vitro. 2020 Aug;66:104877. doi: 10.1016/j.tiv.2020.104877. Epub 2020 May 6.
9
Prediction of Drug-Drug Interactions by Using Profile Fingerprint Vectors and Protein Similarities.利用轮廓指纹向量和蛋白质相似性预测药物相互作用
Healthc Inform Res. 2020 Jan;26(1):42-49. doi: 10.4258/hir.2020.26.1.42. Epub 2020 Jan 31.
10
Machine learning-based identification and rule-based normalization of adverse drug reactions in drug labels.基于机器学习的药物标签中药物不良反应的识别和基于规则的归一化。
BMC Bioinformatics. 2019 Dec 23;20(Suppl 21):707. doi: 10.1186/s12859-019-3195-5.